#

Pfizer

: 26
Pfizer Has Found New Sources of Growth Following a Decline in Sales of COVID-19 Drugs / Photo: Tada Images / Shutterstock.com
News·
Pfizer Raises Annual Revenue Forecast: It Has Found New Sources of Growth in the Wake of COVID
Todays trading will be driven by the markets reaction to Apples earnings report. Photo: VTT Studio/Shutterstock
News·
Morning in New York: The market is under pressure from Apple's earnings report and is awaiting the election results
Apple will report its earnings for the fourth fiscal quarter of 2026 on November 2 after the U.S. market closes / Photo: Tang Yan Song / Shutterstock.com
News·
U.S. Congressional Elections and Apple's Earnings Report: What Investors Can Expect This Week
“We hope this will be like COVID vaccines,” said Stacey Adam, a senior clinical officer at the Foundation for the NIH / Photo: Tada Images / Shutterstock
News·
Moderna hits four-year high as NYT reports U.S. cancer vaccine effort
Novavax was off 13% on Tuesday as of this writing / Photo: Cristian Storto / Shutterstock.com
News·
Vaccine stocks retreat after WHO calls plague risk 'low'
Pfizers experimental lung cancer drug failed to extend patients survival / Photo: Flowersandtraveling / Shutterstock.com
News·
Pfizer's lung cancer drug trial has failed. What will happen to the stock?
Agomab Therapeutics, which is developing treatments for Crohn’s disease, has raised $200 million / Photo: Shutterstock.com / Indah HR
News·
+1
·
Agomab Therapeutics IPO: Pfizer and Sanofi-backed biotech starts trading
Investors remain focused on the personnel reshuffle in the Feds leadership and its impact on guidance on the course of monetary policy / Photo: Shutterstock.com/Kirkam
News·
Morning in New York: investors in search of a foothold
Pfizer has published the first results of studies on an obesity drug/ Photo: Pfizer.com
News·
Pfizer reveals data on obesity drug. Why are analysts and the market disappointed?
Nine major pharma companies have made deals with Trump to lower drug prices
News·
Nine major pharma companies have made deals with Trump to lower drug prices
U.S. to reach drug pricing agreements with Novartis and Roche - Bloomberg
News·
U.S. to reach drug pricing agreements with Novartis and Roche - Bloomberg
Morning in New York: foreign policy news is the markets focus
News·
Morning in New York: foreign policy news is the market's focus
Load more